Long Island University's Brooklyn, N.Y., campus has given C.O. Bigelow Apothecaries owner Ian Ginsberg its Distinguished Alumnus Award, the university said.

Hospira has reappointed its chief scientific officer after he briefly left the country earlier this year, the generic drug maker said.

"Numerous" physicians in Pennsylvania are supporting a bill that would expand the range of immunizations that pharmacists can provide, a state pharmacy group said Thursday.

The Senate voted overwhelmingly to confirm a former Virginia Health and Human Services secretary as administrator of the Centers for Medicare and Medicaid Services.

A federal drug track-and-trace bill has made it out of a congressional committee.

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis, the agency said Wednesday.

A new treatment for late-stage prostate cancer has received approval from the Food and Drug Administration.

According to a study published 10 years ago, depression costs $44 billion per year in lost productivity, but a new program is designed to raise awareness about depression in the workforce and its effects on productivity.

Actavis is continuing to pursue a plan to buy Irish drug maker Warner Chilcott, as the U.S.-based company announced Tuesday its total number of shares and share-purchase options in order to comply with Ireland's merger-and-acquisition rules.

Diplomat Specialty Pharmacy is among the sponsors of a fundraising effort to expand an adult-fitness program run by a Flint, Mich.-based nonprofit.

Medicare Part D plans that create tiered networks of pharmacies for beneficiaries need more oversight amid reports that small and medium-sized pharmacies are being excluded from them, several senators wrote in a letter last week to the Centers for Medicare and Medicaid Services.